Stay updated on Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Sign up to get notified when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.

Latest updates to the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor software version update with no visible changes to the study content or layout.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedSite updated to revision v3.4.2; the previous notice about lapse in government funding (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check44 days agoChange DetectedAdministrative updates: a government funding lapse notice with NIH Clinical Center open status and links, and a page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedLocations section updated: new sites added (Calgary, Kashiwa, Osaka, Seville, Tainan) and several existing locations removed or reformatted. Accompanying metadata such as Last Update and Revision notes were updated.SummaryDifference0.7%

- Check65 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 in the page footer. This is a minor site version update with no changes to study content or outcomes.SummaryDifference0.0%

Stay in the know with updates to Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gevokizumab with Anti-cancer Therapies in Metastatic Cancers Clinical Trial page.